Shawn E. Bearden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shawn E. Bearden has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Richard S. Beard
Department of Biological Sciences, Idaho State University, Pocatello, Idaho, USA
6 shared publications Cheng-Hung Chen
Department of Biological Sciences, Idaho State University, Pocatello, Idaho
2 shared publicationsCheng‐Hung Chen
Department of Biological Sciences, Idaho State University, 921 S. 8th Ave stop 8007, Pocatello, ID, 83209
2 shared publicationsJamie N. Mayo
Department of Biological Sciences, Idaho State University, Pocatello, Idaho
2 shared publications- Jamie N. Mayo
VA Salt Lake City Health Care System, Salt Lake City UT, USA
2 shared publications Jason J. Reynolds
Department of Biological Sciences, Idaho State University, Pocatello ID 83209-8007
2 shared publications
Latest Publications
- Open Access
- 29 October 2020
- Published by Springer Nature in Current Tissue Microenvironment Reports
- Vol. 1 (4) , 199-207
Pericytes as Cell Therapy for Locomotor Recovery
- 29 October 2020
- Published by Springer Nature in Current Tissue Microenvironment Reports
- Vol. 1 (4) , 199-207
Open AccessPericytes as Cell Therapy for Locomotor Recovery
- 30 June 2020
- Published by Wiley in Microcirculation
- Vol. 27 (7)
Pericytes improve locomotor recovery after spinal cord injury in male and female neonatal rats
Objective: It is not known how activation of the hypoxia‐inducible factor (HIF) pathway in pericytes, cells of the microvascular wall, influences new capillary growth. We tested the hypothesis that HIF‐activated pericytes promote angiogenesis in a neonatal model of spinal cord injury (SCI).Methods: Human placental pericytes stimulated with cobalt chloride and naïve pericytes were injected into the site of a thoracic hemi‐section of the spinal cord in rat pups on postnatal day three (P3). Hindlimb motor recovery and Doppler blood flow perfusion at the site of transection were measured on P10. Immunohistochemistry was used to visualize vessel and neurofilament density for quantification.Results: Injection of HIF‐activated pericytes resulted in greater vascular density in males but did not result in improved motor function for males or females. Injection of non–HIF‐activated pericytes resulted improved motor function recovery in both sexes (males, 2.722 ± 0.31‐fold score improvement; females, 3.824 ± 0.58‐fold score improvement, P < .05) but produced no significant changes in vessel density.Conclusions: HIF‐activated pericytes promote vascular density in males post‐SCI. Acute delivery of non–HIF‐activated pericytes at the site of injury can improve motor recovery post‐SCI.
- 30 June 2020
- Published by Wiley in Microcirculation
- Vol. 27 (7)
Pericytes improve locomotor recovery after spinal cord injury in male and female neonatal rats
Objective: It is not known how activation of the hypoxia‐inducible factor (HIF) pathway in pericytes, cells of the microvascular wall, influences new capillary growth. We tested the hypothesis that HIF‐activated pericytes promote angiogenesis in a neonatal model of spinal cord injury (SCI).Methods: Human placental pericytes stimulated with cobalt chloride and naïve pericytes were injected into the site of a thoracic hemi‐section of the spinal cord in rat pups on postnatal day three (P3). Hindlimb motor recovery and Doppler blood flow perfusion at the site of transection were measured on P10. Immunohistochemistry was used to visualize vessel and neurofilament density for quantification.Results: Injection of HIF‐activated pericytes resulted in greater vascular density in males but did not result in improved motor function for males or females. Injection of non–HIF‐activated pericytes resulted improved motor function recovery in both sexes (males, 2.722 ± 0.31‐fold score improvement; females, 3.824 ± 0.58‐fold score improvement, P < .05) but produced no significant changes in vessel density.Conclusions: HIF‐activated pericytes promote vascular density in males post‐SCI. Acute delivery of non–HIF‐activated pericytes at the site of injury can improve motor recovery post‐SCI.
- Open Access
- 1 May 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 474 (2) , 291-295
Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers
- 1 May 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 474 (2) , 291-295
Open AccessMaternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers
- 1 November 2015
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 309 (9) , C600-C607
The connexin 43/ZO-1 complex regulates cerebral endothelial F-actin architecture and migration
Endothelial cell migration is a fundamental process during angiogenesis and, therefore, a point of intervention for therapeutic strategies aimed at controlling pathologies involving blood vessel growth. We sought to determine the role of the gap junction protein connexin 43 (Cx43) in key features of angiogenesis in the central nervous system. We used an in vitro model to test the hypothesis that a complex of interacting proteins, including Cx43 and zonula occludens-1 (ZO-1), regulates the migratory behavior of cerebral endothelium. With knockdown and overexpression experiments, we demonstrate that the rate of healing following scrape-wounding of endothelium is regulated by the level of Cx43 protein expression. The effects on cell motility and proliferation were independent of gap junction communication as cells were sensitive to altered Cx43 expression in single plated cells. Coupling of Cx43/ZO-1 critically regulates this process as demonstrated with the use of a Cx43 α-carboxy terminus 1 peptide mimetic (αCT1) and overexpression of a mutant ZO-1 with the Cx43-binding PDZ2 domain deleted. Disrupting the Cx43/ZO-1 complex with these treatments resulted in collapse of the organized F-actin cytoskeleton and the appearance of actin nodes. Preincubation with the myosin 2 inhibitors blebbistatin or Y-27632 disrupted the Cx43/ZO-1 complex and inhibited cell spreading at the leading edge of migration. Cells studied individually in time-lapse open field locomotion assays wandered less when Cx43/ZO-1 interaction was disrupted without significant change in speed, suggesting that faster wound healing is a product of linearized migration. In contrast to the breakdown of F-actin architecture, microtubule architecture was not obviously affected by treatments. This study provides new insight into the fundamental regulatory mechanisms of cerebral endothelial cell locomotion. Cx43 tethers the F-actin cytoskeleton through a ZO-1 linker and supports cell spreading and exploration during locomotion. Here, we demonstrate that releasing this actin-coupled tether shifts the balance of directional migration control to a more linear movement that enhances the rate of wound healing.
- 1 November 2015
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 309 (9) , C600-C607
The connexin 43/ZO-1 complex regulates cerebral endothelial F-actin architecture and migration
Endothelial cell migration is a fundamental process during angiogenesis and, therefore, a point of intervention for therapeutic strategies aimed at controlling pathologies involving blood vessel growth. We sought to determine the role of the gap junction protein connexin 43 (Cx43) in key features of angiogenesis in the central nervous system. We used an in vitro model to test the hypothesis that a complex of interacting proteins, including Cx43 and zonula occludens-1 (ZO-1), regulates the migratory behavior of cerebral endothelium. With knockdown and overexpression experiments, we demonstrate that the rate of healing following scrape-wounding of endothelium is regulated by the level of Cx43 protein expression. The effects on cell motility and proliferation were independent of gap junction communication as cells were sensitive to altered Cx43 expression in single plated cells. Coupling of Cx43/ZO-1 critically regulates this process as demonstrated with the use of a Cx43 α-carboxy terminus 1 peptide mimetic (αCT1) and overexpression of a mutant ZO-1 with the Cx43-binding PDZ2 domain deleted. Disrupting the Cx43/ZO-1 complex with these treatments resulted in collapse of the organized F-actin cytoskeleton and the appearance of actin nodes. Preincubation with the myosin 2 inhibitors blebbistatin or Y-27632 disrupted the Cx43/ZO-1 complex and inhibited cell spreading at the leading edge of migration. Cells studied individually in time-lapse open field locomotion assays wandered less when Cx43/ZO-1 interaction was disrupted without significant change in speed, suggesting that faster wound healing is a product of linearized migration. In contrast to the breakdown of F-actin architecture, microtubule architecture was not obviously affected by treatments. This study provides new insight into the fundamental regulatory mechanisms of cerebral endothelial cell locomotion. Cx43 tethers the F-actin cytoskeleton through a ZO-1 linker and supports cell spreading and exploration during locomotion. Here, we demonstrate that releasing this actin-coupled tether shifts the balance of directional migration control to a more linear movement that enhances the rate of wound healing.
- 3 August 2015
- Published by Wiley in Microcirculation
- Vol. 22 (8) , 711-723
Driving the Hypoxia‐Inducible Pathway in Human Pericytes Promotes Vascular Density in an Exosome‐Dependent Manner
Objectives: The mechanisms involved in activating pericytes, cells that ensheath capillaries, to engage in the formation of new capillaries, angiogenesis, remain unknown. In this study, the hypothesis was tested that pericytes could be stimulated to promote angiogenesis by driving the HIF pathway.Methods: Pericytes were stimulated with CoCl2 to activate the HIF pathway. Stimulated pericytes were cocultured with endothelial cells in a wound healing assay and in a 3D collagen matrix assay of angiogenesis. A culture system of spinal cord tissue was used to assess microvascular outcomes after treatment with stimulated pericytes. Pharmaceutical inhibition of exosome production was also performed.Results: Treatment with stimulated pericytes resulted in faster wound healing (1.92 ± 0.18 fold increase, p < 0.05), greater endothelial cord formation (2.9 ± 0.14 fold increase, p < 0.05) in cell culture assays, and greater vascular density (1.78 ± 0.23 fold increase, p < 0.05) in spinal cord tissue. Exosome secretion and the physical presence of stimulated pericytes were necessary in the promotion of angiogenic outcomes.Conclusions: These results elucidate a mechanism that may be exploited to enhance features of angiogenesis in the CNS.
- 3 August 2015
- Published by Wiley in Microcirculation
- Vol. 22 (8) , 711-723
Driving the Hypoxia‐Inducible Pathway in Human Pericytes Promotes Vascular Density in an Exosome‐Dependent Manner
Objectives: The mechanisms involved in activating pericytes, cells that ensheath capillaries, to engage in the formation of new capillaries, angiogenesis, remain unknown. In this study, the hypothesis was tested that pericytes could be stimulated to promote angiogenesis by driving the HIF pathway.Methods: Pericytes were stimulated with CoCl2 to activate the HIF pathway. Stimulated pericytes were cocultured with endothelial cells in a wound healing assay and in a 3D collagen matrix assay of angiogenesis. A culture system of spinal cord tissue was used to assess microvascular outcomes after treatment with stimulated pericytes. Pharmaceutical inhibition of exosome production was also performed.Results: Treatment with stimulated pericytes resulted in faster wound healing (1.92 ± 0.18 fold increase, p < 0.05), greater endothelial cord formation (2.9 ± 0.14 fold increase, p < 0.05) in cell culture assays, and greater vascular density (1.78 ± 0.23 fold increase, p < 0.05) in spinal cord tissue. Exosome secretion and the physical presence of stimulated pericytes were necessary in the promotion of angiogenic outcomes.Conclusions: These results elucidate a mechanism that may be exploited to enhance features of angiogenesis in the CNS.
- 22 March 2014
- Published by Wiley in Microcirculation
- Vol. 21 (6) , 541-550
Homocysteine Disrupts Outgrowth of Microvascular Endothelium by an iNOS‐Dependent Mechanism
Objective: To test the hypothesis that Hcy impairs angiogenic outgrowth through an iNOS‐dependent mechanism.Methods: Adult C57Bl/6 mouse choroid explants were used in angiogenic outgrowth assays. Mouse microvascular endothelial cells were studied in culture during scrape‐induced migration and dispersed cell locomotion experiments. Activity of iNOS was manipulated with pharmacology (1400W), siRNA, and by use of choroid explants from iNOS knockout mice (iNOS−/−).Results: Hcy (20 μM) significantly decreased the area of endothelial outgrowth without altering the number of cells in the choroid explant angiogenic assay, resulting in more densely packed outgrowth. Hcy prevented the outward orientation of actin filaments and decreased the number of actin projections along the leading edge of outgrowth. Hcy also slowed outgrowth from the edge of a scraped endothelial monolayer and in cultures of dispersed cells, Hcy impaired cell locomotion without affecting proliferation. Inhibition of iNOS activity rescued the effect of Hcy on area of explant outgrowth, cell density, number of projections, cell locomotion, and rate of outgrowth following scraping.Conclusions: Hcy impairs microvascular endothelial outgrowth, but not proliferation, by disrupting cell locomotion through an iNOS‐dependent mechanism.
- 22 March 2014
- Published by Wiley in Microcirculation
- Vol. 21 (6) , 541-550
Homocysteine Disrupts Outgrowth of Microvascular Endothelium by an iNOS‐Dependent Mechanism
Objective: To test the hypothesis that Hcy impairs angiogenic outgrowth through an iNOS‐dependent mechanism.Methods: Adult C57Bl/6 mouse choroid explants were used in angiogenic outgrowth assays. Mouse microvascular endothelial cells were studied in culture during scrape‐induced migration and dispersed cell locomotion experiments. Activity of iNOS was manipulated with pharmacology (1400W), siRNA, and by use of choroid explants from iNOS knockout mice (iNOS−/−).Results: Hcy (20 μM) significantly decreased the area of endothelial outgrowth without altering the number of cells in the choroid explant angiogenic assay, resulting in more densely packed outgrowth. Hcy prevented the outward orientation of actin filaments and decreased the number of actin projections along the leading edge of outgrowth. Hcy also slowed outgrowth from the edge of a scraped endothelial monolayer and in cultures of dispersed cells, Hcy impaired cell locomotion without affecting proliferation. Inhibition of iNOS activity rescued the effect of Hcy on area of explant outgrowth, cell density, number of projections, cell locomotion, and rate of outgrowth following scraping.Conclusions: Hcy impairs microvascular endothelial outgrowth, but not proliferation, by disrupting cell locomotion through an iNOS‐dependent mechanism.
- 29 March 2013
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 35 (1) , 59-66
Hyperhomocysteinemic Mice Show Cognitive Impairment Without Features of Alzheimer's Disease Phenotype
Hyperhomocysteinemia (HHcy) is associated with cognitive impairment and Alzheimer's disease. Whether this association is mechanistic remains unclear. Here, we used a mouse model to test the hypothesis that HHcy increases levels of amyloid-β (Aβ) transporters in microvessels that form the blood-brain barrier, elevates Aβ content (Aβ40 and Aβ42) in the brain, and impairs cognitive performance. Mice with HHcy and age-matched, non-HHcy controls (Ctrl) were studied in two age groups: adult (6.2 ± 0.4 months of age) and old (19 ± 2.0 months of age). Levels of Aβ transporters, RAGE, LRP1, and Pgp, were not different between HHcy and Ctrl mice. Though there was an increase in overall brain Aβ levels with age, there were no differences between HHcy and Ctrl groups in cortex, hippocampus, or midbrain/diencephalon. Despite the lack of difference in Aβ, old mice with HHcy showed significant cognitive impairment on Morris water maze tests compared with Ctrl mice. We conclude that HHcy leads to cognitive impairment without many of the changes currently thought to be relevant to promoting the AD phenotype.
- 29 March 2013
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 35 (1) , 59-66
Hyperhomocysteinemic Mice Show Cognitive Impairment Without Features of Alzheimer's Disease Phenotype
Hyperhomocysteinemia (HHcy) is associated with cognitive impairment and Alzheimer's disease. Whether this association is mechanistic remains unclear. Here, we used a mouse model to test the hypothesis that HHcy increases levels of amyloid-β (Aβ) transporters in microvessels that form the blood-brain barrier, elevates Aβ content (Aβ40 and Aβ42) in the brain, and impairs cognitive performance. Mice with HHcy and age-matched, non-HHcy controls (Ctrl) were studied in two age groups: adult (6.2 ± 0.4 months of age) and old (19 ± 2.0 months of age). Levels of Aβ transporters, RAGE, LRP1, and Pgp, were not different between HHcy and Ctrl mice. Though there was an increase in overall brain Aβ levels with age, there were no differences between HHcy and Ctrl groups in cortex, hippocampus, or midbrain/diencephalon. Despite the lack of difference in Aβ, old mice with HHcy showed significant cognitive impairment on Morris water maze tests compared with Ctrl mice. We conclude that HHcy leads to cognitive impairment without many of the changes currently thought to be relevant to promoting the AD phenotype.
- 1 March 2012
- Published by Elsevier in Vascular Pharmacology
- Vol. 56 (3-4) , 159-167
Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine
- 1 March 2012
- Published by Elsevier in Vascular Pharmacology
- Vol. 56 (3-4) , 159-167
Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine
- 5 January 2012
- Published by Wiley in Microcirculation
- Vol. 19 (4) , 285-295
Homocysteine Impairs Endothelial Wound Healing by Activating Metabotropic Glutamate Receptor 5
Please cite this paper as:Chen C‐H, Beard RS, Bearden SE. Homocysteine impairs endothelial wound healing by activating metabotropic glutamate receptor 5.Microcirculation19: 285–295, 2012. Objective: Hcy is an independent risk factor for cerebrovascular disease and cognitive impairment. The purpose of this study was to elucidate the role of mGluR5 in Hcy‐mediated impairment of cerebral endothelial wound repair.Methods: Mouse CMVECs (bEnd.3) were used in conjunction with directed pharmacology and shRNA. AutoDock was used to simulate the docking of ligand–receptor interactions.Results: Hcy (20 μM) significantly increased Cx43‐pS368 by mGluR5‐ and PKC‐dependent mechanisms. Hcy attenuated wound repair by an mGluR5‐dependent mechanism over the six‐day study period but did not alter cell proliferation in a proliferation assay, suggesting that the attenuation of wound repair may be due to dysfunctional migration in HHcy. Hcy increased the expression of Cx43 and Cx43‐pS368 at the wound edge by activating mGluR5. Direct activation of mGluR5, using the specific agonist CHPG, was sufficient to reproduce the results whereas KO of mGluR5 with shRNA, or inhibition with MPEP, blocked the response to Hcy.Conclusions: Inhibition of mGluR5 activation could be a novel strategy for promoting endothelial wound repair in patients with HHcy. Activation of mGluR5 may be a viable strategy for disrupting angiogenesis.
- 5 January 2012
- Published by Wiley in Microcirculation
- Vol. 19 (4) , 285-295
Homocysteine Impairs Endothelial Wound Healing by Activating Metabotropic Glutamate Receptor 5
Please cite this paper as:Chen C‐H, Beard RS, Bearden SE. Homocysteine impairs endothelial wound healing by activating metabotropic glutamate receptor 5.Microcirculation19: 285–295, 2012. Objective: Hcy is an independent risk factor for cerebrovascular disease and cognitive impairment. The purpose of this study was to elucidate the role of mGluR5 in Hcy‐mediated impairment of cerebral endothelial wound repair.Methods: Mouse CMVECs (bEnd.3) were used in conjunction with directed pharmacology and shRNA. AutoDock was used to simulate the docking of ligand–receptor interactions.Results: Hcy (20 μM) significantly increased Cx43‐pS368 by mGluR5‐ and PKC‐dependent mechanisms. Hcy attenuated wound repair by an mGluR5‐dependent mechanism over the six‐day study period but did not alter cell proliferation in a proliferation assay, suggesting that the attenuation of wound repair may be due to dysfunctional migration in HHcy. Hcy increased the expression of Cx43 and Cx43‐pS368 at the wound edge by activating mGluR5. Direct activation of mGluR5, using the specific agonist CHPG, was sufficient to reproduce the results whereas KO of mGluR5 with shRNA, or inhibition with MPEP, blocked the response to Hcy.Conclusions: Inhibition of mGluR5 activation could be a novel strategy for promoting endothelial wound repair in patients with HHcy. Activation of mGluR5 may be a viable strategy for disrupting angiogenesis.
- Open Access
- 21 December 2011
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 32 (5) , 825-834
Nitrative Stress in Cerebral Endothelium is Mediated by mGluR5 in Hyperhomocysteinemia
Hyperhomocysteinemia (HHcy) disrupts nitric oxide (NO) signaling and increases nitrative stress in cerebral microvascular endothelial cells (CMVECs). This is mediated, in part, by protein nitrotyrosinylation (3-nitrotyrosine; 3-NT) though the mechanisms by which extracellular homocysteine (Hcy) generates intracellular 3-NT are unknown. Using a murine model of mild HHcy ( cbs+/– mouse), we show that 3-NT is significantly elevated in cerebral microvessels with concomitant reductions in serum NO bioavailability as compared with wild-type littermate controls ( cbs+/+). Directed pharmacology identified a receptor-dependent mechanism for 3-NT formation in CMVECs. Homocysteine increased expression of inducible NO synthase (iNOS) and formation of 3-NT, both of which were blocked by inhibition of metabotropic glutamate receptor-5 (mGluR5) with the specific antagonist 2-methyl-6-(phenylethynyl) pyridine hydrochloride. Activation of mGluR5 is both sufficient and necessary to drive the nitrative stress because direct activation using the mGluR5-specific agonist (RS)-2-chloro-5-hydroxyphenylglycine also increased iNOS expression and 3-NT formation while knockdown of mGluR5 receptor expression by short hairpin RNA (shRNA) blocked their increase in response to Hcy. Nitric oxide derived from iNOS was required for Hcy-mediated formation of 3-NT because the effect was blocked by 1400 W. These results provide the first evidence for a receptor-dependent process that explains how plasma Hcy levels control intracellular nitrative stress in cerebral microvascular endothelium.
- 21 December 2011
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 32 (5) , 825-834
Open AccessNitrative Stress in Cerebral Endothelium is Mediated by mGluR5 in Hyperhomocysteinemia
Hyperhomocysteinemia (HHcy) disrupts nitric oxide (NO) signaling and increases nitrative stress in cerebral microvascular endothelial cells (CMVECs). This is mediated, in part, by protein nitrotyrosinylation (3-nitrotyrosine; 3-NT) though the mechanisms by which extracellular homocysteine (Hcy) generates intracellular 3-NT are unknown. Using a murine model of mild HHcy ( cbs+/– mouse), we show that 3-NT is significantly elevated in cerebral microvessels with concomitant reductions in serum NO bioavailability as compared with wild-type littermate controls ( cbs+/+). Directed pharmacology identified a receptor-dependent mechanism for 3-NT formation in CMVECs. Homocysteine increased expression of inducible NO synthase (iNOS) and formation of 3-NT, both of which were blocked by inhibition of metabotropic glutamate receptor-5 (mGluR5) with the specific antagonist 2-methyl-6-(phenylethynyl) pyridine hydrochloride. Activation of mGluR5 is both sufficient and necessary to drive the nitrative stress because direct activation using the mGluR5-specific agonist (RS)-2-chloro-5-hydroxyphenylglycine also increased iNOS expression and 3-NT formation while knockdown of mGluR5 receptor expression by short hairpin RNA (shRNA) blocked their increase in response to Hcy. Nitric oxide derived from iNOS was required for Hcy-mediated formation of 3-NT because the effect was blocked by 1400 W. These results provide the first evidence for a receptor-dependent process that explains how plasma Hcy levels control intracellular nitrative stress in cerebral microvascular endothelium.